Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome [Phase 3]

View source ↗

Summary

This Phase 3 clinical study is evaluating the safety, tolerability, and pharmacokinetics of fenfluramine hydrochloride in infants aged 1 year to less than 2 yea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• fenfluramine hydrochloride (Fintepla) (fenfluramine hydrochloride)

Snippet

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Dravet Syndrome | Phase 3 | Status: ACTIVE_NOT_RECRUITING